When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALBO - Albireo initiates late-stage study of Odevixibat in pediatric liver disease
Albireo Pharma Inc.
Albireo Pharma (ALBO+1.9%)has enrolled first patient in global Phase 3 trial (BOLD) of odevixibat for biliary atresia, expanding the development of odevixibat to a second rare cholestatic liver disease indication.
More news on: Albireo Pharma, Inc., Healthcare stocks news,